Why Shopify Stock’s Steep Upside Might Be Over

Looking for a stock to trim this fall? Consider selling shares in Shopify (TSX:SHOP)(NYSE:SHOP) if you’re bullish on a vaccine.

| More on:

The premier Canadian tech name and e-commerce frontrunner, Shopify (TSX:SHOP)(NYSE:SHOP) should have carried on soaring this week. Its record third-quarter profit beat smashed expectations and delivered year-on-year three-month growth of 96%. But instead, investors started selling, and by midday this name was sitting on a scant 0.9% five-day gain.

Why? The theories are many. But one culprit is looking particularly guilty right now. Look no further than Shopify’s nemesis, Moderna (NASDAQ:MRNA). These two stocks have faced off before. In fact, the first significant tech stock selloff of the year was preceded by good news from Moderna. That time around, Shopify ditched more than 10%. And now? Friday saw Shopify negative by 9% for the week, in a post-earnings slump that coincided with a vaccine breakthrough.

The tech stock space has vaccine allergies

The news that Moderna is readying its COVID-19 vaccine rollout should be cause for celebration across the markets. The problem for tech stocks, though, is that an economic recovery doesn’t jive with the “stay-at-home” thesis that launched certain tech stock names sky high. Chief among the tech stocks that has benefited from a lockdown is internet shopping outfit Shopify.

The fact that Shopify’s steep growth in 2020 is fundamentally unsustainable only adds to the pullback trend in overvalued tech names. Investors should consider that other mighty names have also been faltering of late. From Netflix to Microsoft, it would seem no tech stock is safe anymore.

Of course, e-commerce is far from over as a growth trend. In the post-pandemic age, digitalization not only guards against the societal fallout of future outbreaks but also bolsters business efficiencies and facilitates easy at-home and on-the-move consumerism. The issue with Shopify, though, is that the exponential growth that it enjoyed during the early days of the pandemic is not replicable.

An asset type to trim and build

Looking for a stock to trim this fall? Consider selling shares in Shopify if you’re bullish on a vaccine. We’ve seen a couple of times now that Shopify has developed an allergy to vaccine breakthroughs. Investors should therefore expect a full recovery, an end to the pandemic, and the cessation of lockdowns to take big bites out of this overvalued tech stock’s share price.

Friday saw tech stocks either side of the border serving up further signals of an upcoming asset class-wide correction. Buying opportunities might very well be in the making, with Big Tech tickers likely to flash red next month. This could help to weigh on the markets in a broader sense — consider the recent mini-crash preceded by the Apple and Tesla stock splits.

Given the potential for volatility already present in the markets, the overvaluation of tech stocks is therefore both a viability and an opportunity. Overvaluation is likely to add to the two-for-one volatility of an ongoing pandemic and a hotly contested U.S. election. But the downside could allow investors who, up till now, have sat out the race to upside to gain entry points at more reasonable valuations.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. David Gardner owns shares of Apple, Netflix, and Tesla. Tom Gardner owns shares of Netflix, Shopify, and Tesla. The Motley Fool owns shares of and recommends Apple, Microsoft, Netflix, Shopify, Shopify, and Tesla and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft.

More on Tech Stocks

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is POET Technologies a Top AI Stock for Canadian Investors?

Canada has relatively few AI stocks, and the ones it has are different from American AI stocks in terms of…

Read more »

Rocket lift off through the clouds
Tech Stocks

2 Growth Stocks That Could Skyrocket in 2025 and Beyond

Wondering what types of stocks could rapidly rise in 2025? Check out these two stocks with substantial upside if they…

Read more »

up arrow on wooden blocks
Tech Stocks

The 3 Smartest Tech Stocks to Buy With $500 Right Now

Tech stocks can be seen as a bit risky, but these three have far less risk and more stability for…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

Shopify: A Must-Have Growth Stock for Your TFSA Now (and the Next 10 Years)

Shopify (TSX:SHOP) stock isn't just a top growth company, it's a titan worth owning in your decades-long TFSA fund.

Read more »

cloud computing
Tech Stocks

Best Stock to Buy Right Now: Manulife vs CIBC

Want the best stocks? These two are certainly the best options. But which is the better buy?

Read more »

profit rises over time
Tech Stocks

4 Reasons to Buy Constellation Software Stock Like There’s No Tomorrow

Constellation Software stock continued its climb upwards after recent earnings, and this only adds to its appeal.

Read more »

calculate and analyze stock
Tech Stocks

1 Stock That’s Just as Hot as Nvidia (Without All the Hype)

Nvidia stock may look like a strong option, but its valuation is through the roof. Enter this other under-the-radar stock.

Read more »

A plant grows from coins.
Tech Stocks

3 Growth Stocks Wall Street Might Be Sleeping on, But I’m Not

Don’t miss your chance to load up on these three beaten-down stocks.

Read more »